# Study of DM5167 in Patients With Advanced Solid Tumors

> **NCT07101601** · PHASE1 · RECRUITING · sponsor: **DIGMBIO** · enrollment: 58 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** DM5167

## Key facts

- **NCT ID:** NCT07101601
- **Lead sponsor:** DIGMBIO
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-24
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07101601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07101601, "Study of DM5167 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07101601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*